ADEAR

Alzheimer's Disease

Caregiving

Health Info

Publications

Resources

ADEAR Home > News > TAP/DAP Trial

NIA News: AD Research Update

New AD Statin Study, Updated TAP/DAP Trial Now Recruiting

February 2003

Two large clinical trials to examine Alzheimer's disease treatment and
prevention, sponsored by the Alzheimer's Disease Cooperative Study and funded by the National Institute on Aging, are now underway and recruiting volunteers at sites nationwide.

Click on the study title below to go to its complete description and list of sites.

• NEW! Cholesterol Lowering Agent to Slow Progression of AD (CLASP) -
  seeks 400 participants age 50 and older with mild to moderate AD to test the effectiveness of the cholesterol-lowering statin drug simvastatin (brand name Zocor) in slowing AD. 40 study sites in the U.S.
  
  
• Updated! Treatment of Agitation/Psychosis in Dementia and
  Parkinsonism (TAP/DAP) - seeks patients with a primary
  dementia (probable Alzheimer's disease or dementia with Lewy bodies,
  also now includes Parkinson's disease with dementia) complicated by
  coexistent parkinsonism to test the efficacy and tolerability of
  quetiapine and donepezil, used alone or in combination, to treat
  psychosis and/or agitation. 20 study sites in the U.S.

For information on additional AD studies, go to the ADEAR Clinical Trials Database.

###

Questions about Alzheimer's Disease?
E-mail our Information Specialists or call toll-free, 1-800-438-4380.